| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Studies |
Pennington Biomedical Research Center and Louisiana State University School of Medicine; and the Departments of Psychology (D.G.) and Experimental Statistics (R.M.), Louisiana State University, Baton Rouge, Louisiana 70808
Address all correspondence and requests for reprints to: Jennifer C. Lovejoy, Ph.D., Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, Louisiana 70808-4124. E-mail: lovejoj{at}mhs.pbrc.edu
Although T3 exerts major regulatory actions in both animals and humans, most clinical studies of T3 administration have been relatively short term. The present study examined the effects of more than 2 months (63 days) of low dose T3 treatment on nitrogen balance, body composition, 24-h energy expenditure (EE), and protein turnover in seven healthy men studied at an in-patient metabolic unit. Subjects were also randomly assigned to either high or low fat diets to determine the effects of diet composition. T3 treatment produced significant losses in both lean mass (1.5 ± 0.3 kg) and fat mass (2.7 ± 0.4 kg) by 6 weeks, with similar reductions in both at 9 weeks. The high fat diet somewhat attenuated the loss of body fat. Nitrogen balance was significantly negative for the first 3 weeks of T3 treatment, but tended to return to baseline thereafter. There were no significant effects of treatment on protein turnover at 9 weeks, although there was a slight increase in leucine oxidation (P = 0.07). Despite the apparent adaptation in nitrogen balance, total 24-h EE and sleeping EE were significantly increased at 9 weeks. We conclude that although healthy men are able to adapt to mild hyperthyroidism in terms of nitrogen balance, they exhibit significant and persistent changes in fat and fat-free mass as well as energy balance.
This article has been cited by other articles:
![]() |
A. L. D. Riis, J. O. L. Jorgensen, P. Ivarsen, J. Frystyk, J. Weeke, and N. Moller Increased Protein Turnover and Proteolysis Is an Early and Primary Feature of Short-Term Experimental Hyperthyroidism in Healthy Women J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3999 - 4005. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Short, J. Nygren, and K. S. Nair Effect of T3-induced hyperthyroidism on mitochondrial and cytoplasmic protein synthesis rates in oxidative and glycolytic tissues in rats Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E642 - E647. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Kong, N. M. Martin, K. L. Smith, J. V. Gardiner, I. P. Connoley, D. A. Stephens, W. S. Dhillo, M. A. Ghatei, C. J. Small, and S. R. Bloom Triiodothyronine Stimulates Food Intake via the Hypothalamic Ventromedial Nucleus Independent of Changes in Energy Expenditure Endocrinology, November 1, 2004; 145(11): 5252 - 5258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Park, S. R. Paulsen, S. R. Gammon, K. J. Mustard, D. G. Hardie, and W. W. Winder Effects of thyroid state on AMP-activated protein kinase and acetyl-CoA carboxylase expression in muscle J Appl Physiol, December 1, 2002; 93(6): 2081 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Bray and F. L. Greenway Current and Potential Drugs for Treatment of Obesity Endocr. Rev., December 1, 1999; 20(6): 805 - 875. [Abstract] [Full Text] |
||||
![]() |
J. C. Lovejoy, S. R. Smith, J. J. Zachwieja, G. A. Bray, M. M. Windhauser, P. J. Wickersham, J. D. Veldhuis, R. Tulley, and J. A. de la Bretonne Low-dose T3 improves the bed rest model of simulated weightlessness in men and women Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E370 - E379. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |